Maturity-onset diabetes of the young (MODY) type 2 is caused by heterozygous inactivating mutations in the gene encoding glucokinase (GCK), a pivotal enzyme for glucose homeostasis. In the pancreas GCK regulates insulin secretion, while in the liver it promotes glucose utilization and storage. We showed that silencing the orthologs and results in a MODY-2-like hyperglycemia. Targeted knock-down revealed that is expressed in insulin producing cells (IPCs) whereas is specifically expressed in the fat body. We showed that is essential for insulin secretion and it is required for expression. Reduced levels of either Hex-A or Hex-C resulted in chromosome aberrations (CABs), together with an increased production of advanced glycation end-products (AGEs) and reactive oxygen species (ROS). This result suggests that CABs, in GCK depleted cells, are likely due to hyperglycemia, which produces oxidative stress through AGE metabolism. In agreement with this hypothesis, treating GCK-depleted larvae with the antioxidant vitamin B6 rescued CABs, whereas the treatment with a B6 inhibitor enhanced genomic instability. Although MODY-2 rarely produces complications, our data revealed the possibility that MODY-2 impacts genome integrity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831483PMC
http://dx.doi.org/10.3390/ijms22020918DOI Listing

Publication Analysis

Top Keywords

genomic instability
8
oxidative stress
8
insulin secretion
8
functional inactivation
4
inactivation orthologs
4
orthologs genomic
4
instability oxidative
4
stress fly
4
fly model
4
model mody-2
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!